The CRO Leadership Awards

In cooperation with Life Science Leader, Nice Insight is pleased to announce the results of the first
annual CRO Leadership Awards.

Nice Insight combines surveying of thousands of industry executives with other key analyses to
serve both partnering groups and facilitate better overall outsourcing collaborations. Life Science
Leader developed the annual CRO Leadership Awards to honor top performers based on responses
and better serve pharmaceutical and biopharmaceutical executives in their CRO vetting process.

Leaders in Bioanalytical — Quality

SERVICE AREAS: Bioanalytical
	Accugenix, Inc. "Accugenix provides accurate, fast and cost effective microbe species identification and strain typing services. By using innovative technologies like DNA sequencing and MALDI-TOF and developing full coverage libraries, Accugenix has become the industry leader. Production risk is minimized with the accurate identification of microbes. Online sample submission, sample status and identification reports, along with our staff of experts are committed to providing high quality, cost effective and fully supported solutions." Douglas Smith — President and Chief Executive Officer
SERVICE AREAS: Bioanalytical, Preclinical
	Critical Path Services, LLC "Our clients appreciate our focus on meeting their needs. The regulated sciences is a complex industry and our clients have many demands with little room for error. As a company our chosen core values are passion for excellence, integrity in practice, and drive with flexibility. Our staff all strive to live this daily and find ways to keep our customers delighted with our work products." Julie Eble, PhD — CEO
SERVICE AREAS: Bioanalytical, Preclinical
	Exova "Exova prides itself on servicing its pharmaceutical and medical device customers to their complete satisfaction. We take great care to ensure our test results are of the highest quality and delivered on time in an efficient manner.  Our strengths are our people and our trusted client relationships." Michael Hincks — Executive Vice President of Health Sciences, Americas
SERVICE AREAS: Bioanalytical, Preclinical, Clinical
	ICON plc "ICON’s leadership ranking in this industry survey is testament to the expertise and dedication of ICON employees around the world who deliver quality programs to clients. We will continue to be a proactive and innovative provider of solutions that help clients maximise the effectiveness of their R&D activities and bring new drugs to market more cost effectively and efficiently." Dr. Steve Cutler — Group President, Clinical Research Services
SERVICE AREAS: Bioanalytical, Clinical
	Quintiles "We are honored to be recognized for our leadership in clinical research - which is ultimately about improving human health and saving lives. Quintiles employees worldwide are committed to developing new ways to improve the quality, reliability and productivity of clinical research, helping speed the approval of new medicines for patients. Together with our customers, we're creating a new model of drug development that leverages expertise and data to make better decisions faster." Paula Brown Stafford — Exec VP, Clinical Development
SERVICE AREAS: Bioanalytical, Clinical
	SGS Life Science Services "As the world’s leading inspection, testing, certification and verification company, SGS takes great pride in providing independent high quality services across all the industries we serve, adhering to a strict code of integrity. We work hard to develop customized solutions for each of our clients to significantly improve their drug development timelines and decision-making processes. Each department from the clinical pharmacology group to project management, biometrics and pharmacovigilance works together to exceed our client’s expectations." Anne Hays — Executive Vice President
SERVICE AREAS: Bioanalytical, Preclinical, Clinical
	SSCI, a division of Aptuit "SSCI, a division of Aptuit, is honored to be recognized for the superior quality of our scientific expertise in solid state chemistry and analytical research. We take great pride in our position as the industry leader in this crucial segment of drug development. As we move forward, we will continue to deliver scientific excellence to our clients by accelerating the pace at which they develop their products and improving the quality of the drugs that they provide to consumers around the world." Pamela A. Smith, Ph.D. — Senior Director, Site Director